Skip to main content

Table 4 Multivariate analysis including MTC02 expression status in (A) all cancers, (B) ERG negative and (C) ERG positive prostate cancers

From: High mitochondria content is associated with prostate cancer disease progression

A         
Scenario (n) preoperative PSA-level pT stage cT stage Gleason grade prostatectomy Biopsy gleason grade N status R status MTC02 expression
1 (4,433) < 0.0001 < 0.0001   < 0.0001   < 0.0001 < 0.0001 0.656
2 (7,226) < 0.0001 < 0.0001   < 0.0001    < 0.0001 0.8726
3 (7,078) < 0.0001   < 0.0001 < 0.0001     0.1282
4 (6,974) < 0.0001   < 0.0001   < 0.0001    0.0007
B         
1 (2,220) 0.0026 < 0.0001   < 0.0001   < 0.0001 0.0063 0.7664
2 (3,528) < 0.0001 < 0.0001   < 0.0001    0.0002 0.8366
3 (3,489) < 0.0001   < 0.0001 < 0.0001     0.7614
4 (3,442) < 0.0001   < 0.0001   < 0.0001    0.0384
C         
1 (1,791) 0.0117 < 0.0001   < 0.0001   0.0118 0.003 0.7873
2 (2,884) 0.0002 < 0.0001   < 0.0001    < 0.0001 0.8902
3 (2,798) < 0.0001   < 0.0001 < 0.0001     0.2321
4 (2,752) < 0.0001   < 0.0001   < 0.0001    0.3955